Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

Schjerning Olsen AM, Gislason GH, McGettigan P, Fosbøl E, Sørensen R, Hansen ML, Køber L, Torp-Pedersen C, Lamberts M.

JAMA. 2015 Feb 24;313(8):805-14. doi: 10.1001/jama.2015.0809.

PMID:
25710657
2.

[Magnetic resonance imaging as supplement to clinical examination by suspicion of haematocolpos.]

Rivero FY, Holst AK, Sørensen RG.

Ugeskr Laeger. 2015 Jan 26;177(2A). pii: V02130118. Danish.

PMID:
25612983
3.

Nationwide trends in use and timeliness of diagnostic coronary angiography in acute coronary syndromes from 2005 to 2011: Does distance to invasive heart centres matter?

Hansen KW, Sørensen R, Madsen M, Madsen JK, Jensen JS, von Kappelgaard LM, Mortensen PE, Galatius S.

Eur Heart J Acute Cardiovasc Care. 2014 Dec 4. pii: 2048872614562968. [Epub ahead of print]

PMID:
25477476
4.

Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.

Jeger RV, Pfisterer ME, Sørensen R, von Felten S, Alber H, Bonetti PO, Eberli F, Erne P, Pedrazzini G, Rickli H, Galatius S, Kaiser CA; BASKET and BASKET-PROVE investigators.

Am Heart J. 2014 Nov;168(5):698-705. doi: 10.1016/j.ahj.2014.07.019. Epub 2014 Jul 30.

PMID:
25440798
5.

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

Olesen JB, Sørensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, Køber L, Gislason GH, Torp-Pedersen C, Fosbøl EL.

Europace. 2015 Feb;17(2):187-93. doi: 10.1093/europace/euu225. Epub 2014 Sep 18.

PMID:
25236181
6.

Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.

Juul N, Gislason G, Olesen JB, Lamberts M, Hansen ML, Karasoy D, Christiansen CB, Torp-Pedersen C, Sorensen R.

Eur Heart J Acute Cardiovasc Care. 2014 Jun 16. pii: 2048872614538848. [Epub ahead of print]

PMID:
24936092
7.

Triple antithrombotic therapy: risky but sometimes necessary.

Sørensen R, Gislason G.

Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):171-5. doi: 10.1016/j.rec.2013.08.010. Epub 2013 Nov 28. No abstract available.

PMID:
24774390
8.

Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial.

Pedersen SH, Pfisterer M, Kaiser C, Jensen JS, Alber H, Rickenbacher P, Sørensen R, Iversen A, Jensen MT, Wadt K, Galatius S; BASKET-PROVE Investigators.

EuroIntervention. 2014 May;10(1):58-64. doi: 10.4244/EIJV10I1A11.

9.

Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.

Lamberts M, Gislason GH, Lip GY, Lassen JF, Olesen JB, Mikkelsen AP, Sørensen R, Køber L, Torp-Pedersen C, Hansen ML.

Circulation. 2014 Apr 15;129(15):1577-85. doi: 10.1161/CIRCULATIONAHA.113.004834. Epub 2014 Jan 27.

10.

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study.

Sørensen R, Gislason G, Torp-Pedersen C, Olesen JB, Fosbøl EL, Hvidtfeldt MW, Karasoy D, Lamberts M, Charlot M, Køber L, Weeke P, Lip GY, Hansen ML.

BMJ Open. 2013 May 3;3(5). pii: e002758. doi: 10.1136/bmjopen-2013-002758.

11.

Dysphagia screening and intensified oral hygiene reduce pneumonia after stroke.

Sørensen RT, Rasmussen RS, Overgaard K, Lerche A, Johansen AM, Lindhardt T.

J Neurosci Nurs. 2013 Jun;45(3):139-46. doi: 10.1097/JNN.0b013e31828a412c.

PMID:
23636069
12.

Prognosis and treatment in patients admitted with acute myocardial infarction on weekends and weekdays from 1997 to 2009.

Hansen KW, Hvelplund A, Abildstrøm SZ, Prescott E, Madsen M, Madsen JK, Jensen JS, Sørensen R, Galatius S.

Int J Cardiol. 2013 Sep 30;168(2):1167-73. doi: 10.1016/j.ijcard.2012.11.071. Epub 2012 Nov 28.

PMID:
23199552
13.

Risk of bleeding related to antithrombotic treatment in cardiovascular disease.

Sørensen R, Olesen JB, Charlot M, Gislason GH.

Curr Pharm Des. 2012;18(33):5362-78. Review.

PMID:
22724419
14.

Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people.

Andersson C, Vaag A, Selmer C, Schmiegelow M, Sørensen R, Lindhardsen J, Gislason GH, Køber L, Torp-Pedersen C.

BMJ Open. 2012 Jun 8;2(3). pii: e000433. doi: 10.1136/bmjopen-2011-000433. Print 2012.

15.

Female sex as a risk factor for stroke in atrial fibrillation.

Prescott E, Sørensen R.

BMJ. 2012 May 30;344:e3789. doi: 10.1136/bmj.e3789. No abstract available.

PMID:
22653983
16.

Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study.

Bretler DM, Hansen PR, Sørensen R, Lindhardsen J, Ahlehoff O, Andersson C, Abildstrøm SZ, Torp-Pedersen C, Gislason GH.

BMJ. 2012 Mar 27;344:e1802. doi: 10.1136/bmj.e1802.

17.

Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 men.

Hvelplund A, Galatius S, Madsen M, Sørensen R, Madsen JK, Iversen AZ, Tilsted HH, Helqvist S, Mortensen PE, Nielsen PH, Prescott E, Abildstrøm SZ.

J Invasive Cardiol. 2012 Jan;24(1):19-24.

18.

Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.

Andersson C, Gislason GH, Jørgensen CH, Hansen PR, Vaag A, Sørensen R, Mérie C, Olesen JB, Weeke P, Schmiegelow M, Norgaard ML, Køber L, Torp-Pedersen C.

Diabetes Res Clin Pract. 2011 Oct;94(1):119-25. doi: 10.1016/j.diabres.2011.07.011. Epub 2011 Aug 9.

PMID:
21831467
19.

Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: insights from a high-volume single-center registry.

Pedersen S, Galatius S, Mogelvang R, Abildstrom SZ, Sorensen R, Galloe A, Abildgaard U, Hansen P, Davidsen U, Iversen A, Bech J, Madsen JK, Jensen JS.

J Invasive Cardiol. 2011 Aug;23(8):328-33.

20.

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

Sørensen RB, Køllgaard T, Andersen RS, van den Berg JH, Svane IM, Straten Pt, Andersen MH.

Cancer Res. 2011 Mar 15;71(6):2038-44. doi: 10.1158/0008-5472.CAN-10-3403.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk